Skip to content

Publication Topic: Patient-Focused Drug Development

Peer Review | Bridging research and practice: enhancing regulatory decisions with pragmatic clinical trials in oncology

Public Comment | Clinical Trial Considerations To Support Accelerated Approval of Oncology Therapeutics

Peer Review | A Study Design to Harmonize Patient-Reported Outcomes Across Data Sets

ABSTRACT ChooseTop of pageAbstract <<INTRODUCTIONCHALLENGES TO ePRO DATA S…A FRAMEWORK TO HARMONIZE …REFERENCES PURPOSE Using patient-reported outcomes (PROs) provides important insights from the patient’s perspective and can be valuable to monitor and manage treatment-related adverse events during cancer treatment. Additionally, the digital administration of PROs (electronic PROs [ePROs]) provides real-time updates to clinical care teams…

Poster | 2022 AACR Annual Meeting | Evaluating the Impact of the RACE Act: An Interim Analysis

White Paper | Broadening the Definition of Tolerability in Cancer Clinical Trials to Better Measure the Patient Experience

Peer Review | Incorporating Patient Advocates in Oncology Clinical Development: Lessons Learned From a Novel Pilot Program

Peer Review | The Value of Addressing Patient Preferences

Abstract Recent scientific progress is, in some cases, leading to transformative new medicines for diseases that previously had marginal or even no treatment options. This offers great promise for people affected by these diseases, but it has also placed stress on the health care system in terms of the growing cost associated with some new interventions. Effort has been taken to…

White Paper | Conference on Clinical Cancer Research 2010 – Panel 3 | Integrating Pain Metrics into Oncologic Clinical and Regulatory Decision-Making

White Paper | Conference on Clinical Cancer Research 2015 – Panel 2 | Capturing Symptomatic Adverse Events From the Patients’ Perspective: The Potential Role of the National Cancer Institute’s PRO-CTCAE Measurement System